Cambridge start-up to manufacture patented drugs at one-third of market price

▴ EQRx
EQRx promise to manufacture innovative non-generic medications at one-third the cost of its competitors.

A recently launched start-up, EQRx, launched itself with a humongous promise of coming up with innovative patented prescription medicines that would be at least as good as those in the market, but at a third of a cost of its rivals.

The start-up has a $200 million venture capital at its disposal. It believes that it can create medicines that cost two-thirds less than the competitors and still make profit.

There is no specification on the diseases that the start up plans to treat, although it is said that the focus would be on cancer, autoimmune disorders and not so rare genetic diseases like cystic fibrosis. The start-up is expected to aim at previously identified biological targets and take advantage of advances in computational approaches to drug development.

Tags : #manufacture #patented #drugs #market #price #international

About the Author

Ashesh Pandia

Related Stories

Loading Please wait...

Trending Now

China ropes in more countries for its COVID-19 vaccine trialsSeptember 29, 2020
Antarctica is still free of Covid-19. Can it stay that way?September 29, 2020
Over 200 travellers from India barred from Dubai flight over invalid Covid-19 testsSeptember 29, 2020
Netherland focuses on more stricker rule to comabt COVID-19 September 29, 2020
WHO aims to provide 120 Million rapid Coronavirus tests for poorer statesSeptember 29, 2020
UN chief on 1 Million COVID-19 deathsSeptember 29, 2020
Bahrain reports 585 Covid-19 cases, 777 recoveriesSeptember 28, 2020
Bringing hepatitis C testing and treatment to underserved communities in MadridSeptember 28, 2020
Polish doctor recovers from severe COVID-19 through rehabilitationSeptember 28, 2020
WHO supports rehabilitation of COVID-19 and other patients in UkraineSeptember 28, 2020
WHO work with migrant camps in Greece September 28, 2020
US employers being sued for COVID-19 infection spread September 28, 2020
Global Coronavirus deaths cross 1 Million markSeptember 28, 2020
Highly effective antibodies identified, may lead to passive COVID-19 vaccineSeptember 26, 2020
Europe has a lot of work to do to prevent COVID-19 transmission :WHOSeptember 26, 2020
Two million Coronavirus deaths : WHO September 26, 2020
Johnson & Johnson COVID-19 vaccine produces strong results September 26, 2020
New York to permanently switch to outdoor dining amid pandemicSeptember 26, 2020
WHO gave blessing for Coronavirus vaccine emergency use programme: ChinaSeptember 26, 2020
US surpasses 7 Million Coronavirus casesSeptember 26, 2020